OneMedNet Inks $10M+ Deal to Fuel AI-Powered Precision Medicine Data
Event summary
- OneMedNet signed a seven-figure, multiyear deal to supply de-identified, multimodal clinical Real World Data (RWD) to an AI-enabled precision medicine company.
- The data will be delivered via OneMedNet’s iRWD™ Platform and used to train AI models and create a licensable derivative dataset.
- OneMedNet earns incremental annual sublicensing revenue each time the derivative dataset is licensed to end users.
- The agreement includes an option to expand data volume and contract value.
- The customer operates a network of over 2,300 healthcare partner sites.
The big picture
OneMedNet’s deal underscores the growing demand for high-quality, first-party healthcare data to train AI models in precision medicine. The agreement highlights the strategic shift toward data monetization through derivative products, positioning OneMedNet as a key player in the AI-driven healthcare data space. The multiyear, seven-figure contract reflects the increasing value placed on longitudinal clinical data in life sciences.
What we're watching
- Revenue Diversification
- How OneMedNet’s sublicensing model will impact long-term revenue streams and profitability.
- Market Expansion
- Whether the deal signals broader adoption of AI-driven precision medicine solutions.
- Data Quality
- The pace at which OneMedNet can scale its first-party data network to meet growing demand.
Related topics
